Farnesyltransferase Inhibitors Progeria
Dec. 23, 2024
Lonafarnib Pre-clinical Drug Supply Program | The Progeria Research Foundation A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model | PNAS Farnesyltransferase inhibitor - Wikipedia Frontiers | Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase Farnesyltransferase inhibitor - Wikipedia Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome | Circulation | Farnesyltransferase Inhibitors Progeria
![PDF] Prelamin A Farnesylation and Progeroid Syndromes* | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2df5ba8df5555e246eb04c0fec79a4f82895e429/2-Figure1-1.png){kind=link}
![PDF] Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–…](https://d3i71xaburhd42.cloudfront.net/bf9741023b493fb7fea471ca783200635778a03e/2-Figure1-1.png){kind=link}
![PDF] Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA…](https://d3i71xaburhd42.cloudfront.net/522530d3ab1284f091f2c9e7b0606dadbef01090/43-Figure4-1.png){kind=link}
![PDF] Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Pat…](https://d3i71xaburhd42.cloudfront.net/80c4f55b4f72e9c100a647a3a4650d4d3f4f9a98/3-Figure1-1.png){kind=link}
